ProCE Banner Activity

Optimizing Outcomes for Patients With Relapsed Metastatic Cervical Cancer

Slideset Download
Download this slideset from a local live webinar to learn how to optimally manage your patients with relapsed cervical cancer.

Released: June 28, 2022

Expiration: June 27, 2023

No longer available for credit.

Share

Faculty

Linda R. Duska

Linda R. Duska, MD, MPH, FACOG, FACS, FASCO

Gynecologic Oncologist
Department of OB GYN/Gynecologic Oncology
University of Virginia School of Medicine
Charlottesville, Virginia

Ritu Salani

Ritu Salani, MD, MBA

Professor and Division Director
OB/GYN and Gynecologic Oncology
University of California, Los Angeles
Los Angeles, California

Shannon N. Westin

Shannon N. Westin, MD, MPH

Associate Professor
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genmab

Seagen

Faculty Disclosure

Primary Author

Linda R. Duska, MD, MPH, FACOG, FACS, FASCO

Gynecologic Oncologist
Department of OB GYN/Gynecologic Oncology
University of Virginia School of Medicine
Charlottesville, Virginia

Linda R. Duska, MD, MPH: research support paid to institution: Advaxis, Arch Therapeutics, Eisai, Genentech, GlaxoSmithKline, ImmunoGen, K-Group Beta, Leap Therapeutics, Lycera, Merck, Mersana Therapeutics, Morab, OncoQuest, Pfizer, Plexxikon, Seagen, Syndax, Tesaro; data safety monitoring board: Inovio Pharmaceuticals; scientific advisory board: Regeneron.

Ritu Salani, MD, MBA

Professor and Division Director
OB/GYN and Gynecologic Oncology
University of California, Los Angeles
Los Angeles, California

Ritu Salani, MD, MBA: consultant/advisor/speaker: Arcus, Genentech, GlaxoSmithKline, Instil Bio, Merck, Regeneron, Seagen.

Shannon N. Westin, MD, MPH

Associate Professor
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Shannon N. Westin, MD, MPH: research support: AstraZeneca, Bayer, Clovis Oncology, Cotinga, GlaxoSmithKline, Mereo, Novartis, OncXerna, Roche/Genentech, Zentalis; consultant: Agenus, AstraZeneca, Caris, Clovis Oncology, Eisai, EQRX, GlaxoSmithKline, ImmunoGen, Karyopharm, Lilly, Merck, Mereo, Mersana, Roche/ Genentech, Vincerx, Zentalis.